Search
Urgent action needed to avoid widespread shortage of in-vitro diagnostic tests
In a new statement, BioMed Alliance highlights its increasing concern about the availability of In Vitro Diagnostic (IVD) testing devices in Europe.
Read moreProgram
Saturday, June 15, 2024 - Presidential Session I
Conducting multinational RCTs in pregnancy to improve maternal health in thrombosis: it CAN be done
Prof. Saskia Middeldorp, The Netherlands
Targeting the epigenome in lymphoma
Prof.
EHA and PTHiT Successfully Conclude the Second Joint Virtual Mini Hematology Tutorial
EHA-PTHiT Mini Hematology Tutorial
November 15-16, 2021
Meeting chairs:
Prof G Gaidano (European Hematology Association)
Prof I Hus (Polish Society of Hematology and Transfusion)
Prof T Robak (Polish Society of Hematology and Transfusion)
After a successful mini Tutorial in April 2021, EHA and PTHiT decided to…
Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma – an open-label, dose escalation followed by open-label extension in a single-arm phase I/II study
Daratumumab is a human CD38 monoclonal antibody being tested against multiple myeloma, but it could also have potential in a broad range of other hematological diseases.
Read moreChairs and Members
Chair (until 2026)Hermann Einsele, Professor of Hematology and Oncology, University Hospital Würzburg (Germany)
Co-chair (until 2026)Arjan van de Loosdrecht, Professor of Hematology and Immunhematology, Amsterdam UMC (The Netherlands)
SWG Steering Committee members
Jorge Sierra, Professor of Hematology, Hospital Santa Creu I Sant Pau…
Connecting experts on inherited anemias and iron defects in Budapest
October 12-14, 2023 – Budapest, Hungary
Meeting Chairs:
Ali Taher, American University of Beirut Medical Center, Beirut, Lebanon
Achille Iolascon, University Federico II of Naples, Naples, Italy
In October 2023 EHA and the Specialized Working Group (SWG) on Red Cell and Iron hosted a…
New GFI1B variants in bleeding and platelet disorders
Platelets restrict blood loss upon vessel damage by formation of a clot (thrombus). Recently, we reported a family with a bleeding and platelet disorder (BPD), which was caused by a defect in the gene GFI1B1.
Read more